PROVIDER PROFILE · NPI 1760481410

Jonathan AnolikMD

PRACTICETEMPLESee all providers at this practice →

EndocrinologyPhiladelphia, PAI

MEDICARE UTILIZATION · PART B · 2024

Total beneficiaries

251

Unique beneficiaries

—

Total services

401

Distinct HCPCS

Medicare payment

$34K

Peer benchmark

Total Medicare services vs. 282 Endocrinology providers in PA — below median (cohort median 794).

PRESCRIBING · PART D · 2024

Total Rx claims

3,425

Beneficiaries

—

Total drug cost

$1.6M

Distinct drugs

Brand share

47.7%

Top prescribed drugs

Levothyroxine Sodium369 claims

Semaglutide199 claims

Dulaglutide172 claims

Metformin Hcl169 claims

Atorvastatin Calcium168 claims

QUALITY · MIPS · 2024

Final MIPS score

81.2

Quality

49.7

Cost

74.2

Improvement activities

40.0

Promoting interop.

100.0

Payment adjustment

0.26%

Group

INDUSTRY PAYMENTS · OPEN PAYMENTS · 2024

No data available for this provider in 2024.

REFERRAL NETWORK

Where Jonathan Anolik's patients come from & go

Directional shared-patient flow from Medicare claims — who sends patients to this provider (inbound) and where this provider's patients go next (outbound). 3 inbound referrers · 0 outbound destinations.

Receives referrals from

Inbound — who sends patients here

Physician	Patients	Visits
Quest Diagnostics Clinical Laboratories Inc Clinical Laboratory · Norristown, PA	100	242
Laboratory Corporation Of America Holdings Clinical Laboratory · Raritan, NJ	84	223
VIRTUA - MEMORIAL HOSPITAL BURLINGTON COUNTY, INC.	22	51

Refers patients to

Outbound — where patients go next

No outbound pairs above the suppression threshold.

Source: CMS Physician Shared Patient Patterns (30-day window, Medicare FFS). Direction = a beneficiary seen by the first provider, then the second, within 30 days; a proxy for referral, not a documented referral. Pairs with fewer than 11 shared beneficiaries are suppressed.

CROSS-REFERENCE

Related data on other Healthparse brands

ProviderScore

OIG/SAM exclusion screening, sanctions history